FREQUENCY OF THROMBOCYTOPENIA AMONG PATIENTS WITH CIRRHOSIS
DOI:
https://doi.org/10.54112/bcsrj.v2024i1.797Keywords:
: Keywords: Liver cirrhosis, Thrombocytopenia, Child-Pugh Score, Body Mass IndexAbstract
Thrombocytopenia is a frequently observed condition in individuals suffering from liver cirrhosis. Objective: To find out the frequency of thrombocytopenia in patients with cirrhosis. Methodology: This cross-sectional study was conducted in the Department of Medicine, Khyber Teaching Hospital, Peshawar, from January 2022 to January 2023. All patients with cirrhosis of duration > six months, with ages of 18-60 years, both genders, and any grade of cirrhosis severity were included in the study. Patients with diseases like malaria, dengue fever, ITP and haematological malignancy, SLE, leukaemia, aplastic anaemia, or on drugs like quinine, penicillin, and digoxin were excluded from the study. Platelet counts were done by sending blood to the hospital laboratory. Result: Mean age was 47.43 ± 6.22 years, mean BMI was 25.29 ± 4.06 kg/m2, and mean disease duration was 14.86 ± 5.36 years. Males were 75 (53.1%), and females were 67 (46.9%). Thrombocytopenia was present in 108 (75.5%) and not in 35 (24.5%) patients. There was no association of age, gender, or Child-Pugh score with the occurrence of thrombocytopenia. Still, the increased BMI and increased disease duration were significantly associated with thrombocytopenia (p-value <0.05). Conclusion: There is quite a high prevalence of thrombocytopenia in patients with liver cirrhosis. The duration of the disease and increased BMI are significantly associated with the occurrence of thrombocytopenia. Further studies are recommended to have further proof.
Downloads
References
Ashraf S, Naeem S. Frequency of hypersplenism in chronic liver disease patients presenting with pancytopenia. Annals of King Edward Medical University. 2010;16(1 SI).
Peck-Radosavljevic M. Thrombocytopenia in liver disease. Canadian Journal of Gastroenterology and Hepatology. 2000;14:60D-6D.
Bucsics T, Lampichler K, Vierziger C, Schoder M, Wolf F, Bauer D, et al. Covered transjugular intrahepatic portosystemic shunt improves hypersplenism-associated cytopenia in cirrhosis. Digestive Diseases and Sciences. 2022;67(12):5693-703.
Qamar AA, Grace ND, Groszmann RJ, Garcia–Tsao G, Bosch J, Burroughs AK, et al. Incidence, prevalence, and clinical significance of abnormal hematologic indices in compensated cirrhosis. Clinical gastroenterology and hepatology. 2009;7(6):689-95.
Afdhal N, McHutchison J, Brown R, Jacobson I, Manns M, Poordad F, et al. Thrombocytopenia associated with chronic liver disease. Journal of hepatology. 2008;48(6):1000-7.
Aster R. Pooling of platelets in the spleen: role in the pathogenesis of. The Journal of clinical investigation. 1966;45(5):645-57.
Koike Y, Yoneyama A, Shirai J, Ishida T, Shoda E, Miyazaki K, et al. Evaluation of thrombopoiesis in thrombocytopenic disorders by simultaneous measurement of reticulated platelets of whole blood and serum thrombopoietin concentrations. Thrombosis and haemostasis. 1998;79(06):1106-10.
Kajihara M, Kato S, Okazaki Y, Kawakami Y, Ishii H, Ikeda Y, et al. A Role of Autoantibody–Mediated Platelet Destruction in Thrombocytopenia in Patients With Cirrhosis. Hepatology. 2003;37(6):1267-76.
Hasan S, Jamdar SF, Alalowi M, Al Beaiji SMAA. Dengue virus: A global human threat: Review of literature. Journal of international society of preventive and community dentistry. 2016;6(1):1-6.
Young NS. Flaviviruses and bone marrow failure. Jama. 1990;263(22):3065-8.
García‐Suárez J, Burgaleta C, Hernanz N, Albarran F, Tobaruela P, Alvarez‐Mon M. HCV‐associated thrombocytopenia: clinical characteristics and platelet response after recombinant α2b‐interferon therapy. British journal of haematology. 2000;110(1):98-103.
Wang C-S, Yao W-J, Wang S-T, Chang T-T, Chou P. Strong association of hepatitis C virus (HCV) infection and thrombocytopenia: implications from a survey of a community with hyperendemic HCV infection. Clinical infectious diseases. 2004;39(6):790-6.
Ballard HS. Hematological complications of alcoholism. Alcoholism, clinical and experimental research. 1989;13(5):706-20.
Sata M, Yano Y, Yoshiyama Y, Ide T, Kumashiro R, Suzuki H, et al. Mechanisms of thrombocytopenia induced by interferon therapy for chronic hepatitis B. Journal of gastroenterology. 1997;32:206-10.
Aizawa N, Enomoto H, Takashima T, Sakai Y, Iwata K, Ikeda N, et al. Thrombocytopenia in pegylated interferon and ribavirin combination therapy for chronic hepatitis C. Journal of gastroenterology. 2014;49:1253-63.
Connell W, Kamm M, Ritchie J, Lennard-Jones J. Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience. Gut. 1993;34(8):1081-5.
Dutta TK, Badhe BA. Ciprofloxacin-induced bone marrow depression. Postgraduate medical journal. 1999;75(887):571-3.
Shaik S, Kazi HA, Ender PT. Rapid-onset piperacillin-tazobactam induced thrombocytopenia. Journal of Pharmacy Practice. 2015;28(2):204-6.
Chen TS, Chen PS. The accomplishments of Sir James Cantlie. Journal of Medical Biography. 1999;7(4):197-9.
Angulo P. Nonalcoholic fatty liver disease. New England Journal of Medicine. 2002;346(16):1221-31.
Vuppalanchi R, Chalasani N. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management. Hepatology. 2009;49(1):306-17.
D'ALESSANDRO AM, Kalayoglu M, Sollinger HW, Hoffmann RM, Reed A, Knechtle SJ, et al. The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation. Transplantation. 1991;51(1):157-63
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 . MAAZ, A HAMEED , S SHAH , N MAZARI , Y SHABBIR
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
